| Disease | A RETROSPECTIVE STUDY WAS PERFORMED ON 360 LABYRINTHINE PATIENTS WHO PRESENTED VERTIGO OR OTHER TYPES OF DIZZINESS, HEARING LOSS, TINNITUS, NAUSEA, AND OTHER SYMPTOMS OF VESTIBULAR ORIGIN. ALL OF THESE PATIENTS HAD BEEN UNSUCCESSFULLY TREATED
BY MEANS OF MANY KINDS OF DRUGS LIKE ANTIHISTAMINICS, ANTICONVULSIVANTS, VASODILATORS, ETC. A COMPLETE OTONEUROLOGICAL EVALUATION WAS CARRIED OUT BEFORE AND AFTER TREATMENT WITH GINKGO BILOBA, INCLUDING EAR, NOSE AND THROAT EXAMINATION, PURE
TONE AUDIOGRAM, DISCRIMINATION SCORES, IMPEDANCIOMETRY AND VECTORNYSTAGMOGRAPHIC TRACINGS OF SPONTANEOUS, GAZE AND POSITIONAL NYSTAGMUS, EYE-TRACKING AND OPTOKINETIC TESTS, TORSION SWING STIMULATION AND CALORIC TEST. THE DOSAGE PRESCRIBED WAS
40 MG(ONE TABLET) OF GINKGO BILOBA 3 TIMES A DAY, DURING 90 CONSECUTIVE DAYS, AS A SOLE MEDICATION, BY ORAL ROUTE. IT WAS OBSERVED THAT 72.2% OF THE PATIENTS WERE CURED OR IMPROVED AND 27.8% OF THE CASES REMAINED INALTERED. NO IMPORTANT SIDE
EFFECTS WERE REGISTERED. THE RESULTS INDICATE THAT GINKGO BILOBA IS A SERIOUS ALTERNATIVE IN THE TREATMENT OF DIZZINESS AND OTHER LABYRINTHINE SYMPTOMS. |